Publikationen in Zusammenarbeit mit Forschern von GlaxoSmithKline (United Kingdom) (9)

2024

  1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  2. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

2022

  1. What are the prospects for antiplatelet agents for thromboprophylaxis in antiphospholipid syndrome?

    Expert Review of Clinical Immunology

2021

  1. Genetic mechanisms of critical illness in COVID-19

    Nature, Vol. 591, Núm. 7848, pp. 92-98

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2018

  1. Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain

    European Journal of Pediatrics, Vol. 177, Núm. 2, pp. 181-192

2015

  1. Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease

    Alzheimer's and Dementia: Translational Research and Clinical Interventions, Vol. 1, Núm. 1, pp. 23-36

2013

  1. Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites

    PLoS Medicine, Vol. 10, Núm. 9